ArticleProtein & cell2022

Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer.

Junru Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.